Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating

Reference Data

ISIN LU2492015610
Valor Number 120608809
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). No guarantee can be given that the investment objective will be achieved.
Peculiarities

Fund Prices

Current Price * 97.74 CHF 23.12.2024
Previous Price * 96.82 CHF 20.12.2024
52 Week High * 113.50 CHF 30.08.2024
52 Week Low * 96.82 CHF 20.12.2024
NAV * 97.74 CHF 23.12.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 282,880,532
Unit/Share Assets *** 1,570,428
Trading Information SIX

Performance

YTD Performance -2.90% 29.12.2023
23.12.2024
1 month -4.96% 25.11.2024
23.12.2024
3 months -11.03% 23.09.2024
23.12.2024
6 months -8.94% 24.06.2024
23.12.2024
1 year -2.63% 27.12.2023
23.12.2024
2 years +0.03% 23.12.2022
23.12.2024
3 years -2.26% 04.08.2022
23.12.2024
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

UnitedHealth Group Inc 6.41%
Eli Lilly and Co 5.30%
AstraZeneca PLC 4.92%
Thermo Fisher Scientific Inc 4.80%
Merck & Co Inc 4.56%
Abbott Laboratories 4.54%
Novartis AG Registered Shares 4.42%
Intuitive Surgical Inc 3.84%
Novo Nordisk AS Class B 3.50%
Vertex Pharmaceuticals Inc 3.37%
Last data update 30.09.2024

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 1.03%
SRRI ***
SRRI date *** 30.04.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 *** Sustainable Investment
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)